# Post- Approval Study on Patients Who Received a HeartWare HVAD® During IDE Trials

> **NCT01832610** · — · COMPLETED · sponsor: **Medtronic Cardiac Rhythm and Heart Failure** · enrollment: 101 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** HeartWare® VAS

## Key facts

- **NCT ID:** NCT01832610
- **Lead sponsor:** Medtronic Cardiac Rhythm and Heart Failure
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2017-11
- **Final completion:** 2018-03
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2019-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01832610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01832610, "Post- Approval Study on Patients Who Received a HeartWare HVAD® During IDE Trials". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01832610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*